In this month’s FutureEconomy BioCanRx President and CEO Stéphanie Michaud discusses the opportunties and benefits to our economy and to the well being of Canadians made possible through investment in translational research and calls for greater and more sustained investment across Canada’s life sciences ecosystem.
